Prospective study of the feasibility and effectiveness of a second-trimester quadruple test for Down syndrome in Thailand

被引:4
|
作者
Kaewsuksai, Peeranan [1 ]
Jitsurong, Siroj [2 ]
机构
[1] Songkhla Hosp, Dept Obstet & Gynecol, Songkhla, Thailand
[2] Prince Songkla Univ, Fac Med Technol, Songkhla, Thailand
关键词
Amniocentesis; Down syndrome; Effectiveness; Prenatal care; Quadruple test; Screening test; Thailand; SERUM; INHIBIN; POPULATION; EXPERIENCE;
D O I
10.1002/ijgo.12290
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the feasibility and effectiveness of a quadruple test for Down syndrome in the second trimester of pregnancy in clinical settings in Thailand. Methods: From October 2015 to September 2016, a prospective study was undertaken in 19 hospitals in Songkhla province, Thailand. Women with a singleton pregnancy of 14-18 weeks were enrolled and underwent the quadruple test. The risk cutoff value was set at 1: 250. All women with a positive test (risk >= 1: 250) were offered amniocentesis. Women were followed up until delivery. Results: Among 2375 women, 206 (8.7%) had a positive quadruple test; 98 (47.6%) of these women voluntarily underwent amniocentesis. Overall, seven pregnancies were complicated with chromosomal abnormalities (2.9 cases in 1000), including four cases of Down syndrome (1.7 in 1000) and three of other abnormalities. The detection, false-positive, and accuracy rates of the quadruple test for Down syndrome were 75.0%, 8.6%, and 91.4%, respectively. Conclusion: The quadruple test was found to be a feasible and efficient method for screening for Down syndrome in the second trimester of pregnancy in a Thai clinical setting. The test should be performed for pregnant women before an invasive test for Down syndrome.
引用
收藏
页码:217 / 221
页数:5
相关论文
共 50 条
  • [31] How to combine first- and second-trimester Down syndrome screening tests
    Benn, P
    Egan, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (06) : S112 - S112
  • [32] Second-trimester ultrasound to detect fetuses with Down syndrome - A meta-analysis
    Smith-Bindman, R
    Hosmer, W
    Feldstein, VA
    Deeks, JJ
    Goldberg, JD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08): : 1044 - 1055
  • [33] Iliac angle as a marker for down syndrome in second-trimester fetuses: CT measurement
    Zook, PD
    Winter, TC
    Nyberg, DA
    RADIOLOGY, 1999, 211 (02) : 447 - 451
  • [34] Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study
    Audibert, F
    Dommergues, M
    Benattar, C
    Taieb, J
    Thalabard, JC
    Frydman, R
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (01) : 26 - 31
  • [35] Combined first-trimester versus second-trimester serum screening for Down syndrome: A cost analysis
    Cusick, W
    Buchanan, P
    Hallahan, TW
    Krantz, DA
    Larsen, JW
    Macri, JN
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) : 745 - 751
  • [36] Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome
    Sermondade, Nathalie
    Dreux, Sophie
    Oury, Jean-Francois
    Muller, Francoise
    PRENATAL DIAGNOSIS, 2009, 29 (08) : 814 - 815
  • [37] Comparing the effectiveness of second-trimester nasal bone hypoplasia (NB) and increased nuchal fold (NF) in down syndrome screening
    Odibo, Anthony
    Gerkowicz, Sabrina
    Sehdev, Harish M.
    Stamilio, David
    Macones, George
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S31 - S31
  • [38] Early second-trimester maternal hyperandrogenemia and subsequent preeclampsia: a prospective study
    Carlsen, SM
    Romundstad, P
    Jacobsen, G
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2005, 84 (02) : 117 - 121
  • [39] Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome
    Muller, F
    Dreux, S
    Lemeur, A
    Sault, C
    Desgrès, J
    Bernard, MA
    Giorgetti, C
    Lemay, C
    Mirallié, S
    Beauchet, A
    PRENATAL DIAGNOSIS, 2003, 23 (13) : 1073 - 1076
  • [40] Second-trimester maternal serum invasive trophoblast antigen: A marker for down syndrome screening
    Pandian, R
    Cole, LA
    Palomaki, GE
    CLINICAL CHEMISTRY, 2004, 50 (08) : 1433 - 1435